Last Thursday, Affluent Medical announced the launch of a €13 million capital increase, news which caused its share price to fall by more than 6% on Friday.

The French medtech company's shares regained some color this Monday, rebounding by 3.3%.

In a reaction note published early this morning, analysts at Invest Securities recommend that investors subscribe to the offer, while lowering their target price to €4.1, compared with €9.2 previously.

For the brokerage firm, the operation will enable the company to extend its financial visibility for eight to 11 months, and to anticipate more comfortably a newsflow deemed attractive over the coming months.

This capital increase should thus, according to Invest Securities, "enable the company to return to valuation levels more in line with its pipeline, and to approach future financing deadlines with greater serenity".

Copyright (c) 2023 CercleFinance.com. All rights reserved.